Terms: = Ovarian cancer AND Beta-hCG AND Treatment
32 results:
1. [Human chorionic gonadotropin-secreting gonadoblastomas in a girl of 45, X Turner syndrome: a case report and literature review].
Zheng RJ; Chen QL; Ma HM; Liu HD; Chen JP; Liang GS; Chen J; Zhang YY; Li S; Guo B; Wang ML; Du M
Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1202-1206. PubMed ID: 36319158
[No Abstract] [Full Text] [Related]
2. A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts.
Ataikiru UO; Iacob ER; Miron I; Popoiu CM; Boia ES
J Pediatr Endocrinol Metab; 2022 Mar; 35(3):363-371. PubMed ID: 34968016
[TBL] [Abstract] [Full Text] [Related]
3. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
[TBL] [Abstract] [Full Text] [Related]
4. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract] [Full Text] [Related]
5. ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract] [Full Text] [Related]
6. Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.
Bian J; Li B; Kou XJ; Wang XN; Sun XX; Ming L
Asian Pac J Cancer Prev; 2014; 15(19):8409-11. PubMed ID: 25339038
[TBL] [Abstract] [Full Text] [Related]
7. ovarian germinoma accelerating the presentation of diabetes mellitus.
Lim YY; Loke KY; Ho CW; Kimpo MS; Lee YS
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e55-6. PubMed ID: 25171445
[TBL] [Abstract] [Full Text] [Related]
8. Pelvic pain, free fluid in pelvis, and human chorionic gonadotropin serum elevation: recurrence of malignant ovarian germ-cell tumor or early pregnancy?
Barczyński B; Rogala E; Nowicka A; Nurzyńska-Flak J; Kotarski J
Eur J Gynaecol Oncol; 2013; 34(5):489-92. PubMed ID: 24475592
[TBL] [Abstract] [Full Text] [Related]
9. Elevated human chorionic gonadotropin and hyperandrogenemia in a woman with Müllerian agenesis.
Schickler RL; Hoffman MS; Plosker SM
Obstet Gynecol; 2014 Feb; 123(2 Pt 2 Suppl 2):465-468. PubMed ID: 24413227
[TBL] [Abstract] [Full Text] [Related]
10. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract] [Full Text] [Related]
11. Serum beta-hcg and CA-125 as tumor markers in a patient with osteosarcoma: case report.
Boss DS; Glen H; Beijnen JH; de Jong D; Wanders J; Evans TR; Schellens JH
Tumori; 2011; 97(1):109-14. PubMed ID: 21528673
[TBL] [Abstract] [Full Text] [Related]
12. Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer.
Hashimoto K; Man S; Xu P; Cruz-Munoz W; Tang T; Kumar R; Kerbel RS
Mol Cancer Ther; 2010 Apr; 9(4):996-1006. PubMed ID: 20371722
[TBL] [Abstract] [Full Text] [Related]
13. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
14. Epithelioid trophoblastic tumor of uterus presenting as an ovarian mass: a diagnostic and therapeutic dilemma.
Shet T; Parage M; Maheshwari A; Nair R; Gupta S; Tongaonkar H; Chinoy R
Indian J Pathol Microbiol; 2008; 51(2):242-4. PubMed ID: 18603694
[TBL] [Abstract] [Full Text] [Related]
15. Elevated serum beta-human chorionic gonadotropin in nonpregnant conditions.
Demirtas E; Krishnamurthy S; Tulandi T
Obstet Gynecol Surv; 2007 Oct; 62(10):675-9; quiz 691. PubMed ID: 17868483
[TBL] [Abstract] [Full Text] [Related]
16. Managing ovarian masses during pregnancy.
Leiserowitz GS
Obstet Gynecol Surv; 2006 Jul; 61(7):463-70. PubMed ID: 16787549
[TBL] [Abstract] [Full Text] [Related]
17. [Infantile choriocarcinoma: an uncommon and curable tumor].
Dumesnil C; Gatbois E; Leverger G
Arch Pediatr; 2005 Dec; 12(12):1721-5. PubMed ID: 16271451
[TBL] [Abstract] [Full Text] [Related]
18. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract] [Full Text] [Related]
19. [Monitoring impact of measurement of urinary beta-human chorionic gonadotropin on orthotopic implantation model of human ovarian carcinoma in athymic nude mice].
Li J; Xing H; Gao QL; Lu YP; Wang SX; Zhang AL; Xi L; Ma D
Ai Zheng; 2002 Sep; 21(9):949-53. PubMed ID: 12508539
[TBL] [Abstract] [Full Text] [Related]
20. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
Gawronska B; Leuschner C; Enright FM; Hansel W
Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
[TBL] [Abstract] [Full Text] [Related]
[Next]
